Top

Published in:

01-08-2009 | Editorial Point of View

Quantification of myocardial blood flow will reform the detection of CAD

Authors: Juhani Knuuti, MD, Sami Kajander, MD, Maija Mäki, MD, Heikki Ukkonen, MD

Published in: Journal of Nuclear Cardiology | Issue 4/2009

Excerpt

The detection of functional consequences of epicardial coronary artery disease (CAD) has established role in guiding the therapy of the disease.1 In addition, the assessment of impairment in microcirculatory reactivity has recently gained more interest. Estimates of myocardial perfusion contain independent prognostic information about future major cardiac events and perfusion assessment is also useful in the monitoring of the effectiveness of risk reduction strategies.1 …

Klocke FJ, Baird MG, Lorell BH, Bateman TM, Messer JV, Berman DS, et al. ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging—executive summary: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASNC Committee to revise the 1995 Guidelines for the Clinical Use of Cardiac Radionuclide Imaging. Circulation 2003;108:1404-18.CrossRefPubMed

Dijkmans PA, Knaapen P, Sieswerda GT, Aiazian E, Visser CA, Lammertsma AA, et al. Quantification of myocardial perfusion using intravenous myocardial contrast echocardiography in healthy volunteers: Comparison with positron emission tomography. J Am Soc Echocardiogr 2006;19:285-93.CrossRefPubMed

Fritz-Hansen T, Hove JD, Kofoed KF, Kelbaek H, Larsson HB. Quantification of MRI measured myocardial perfusion reserve in healthy humans: A comparison with positron emission tomography. J Magn Reson Imaging 2008;27:818-24.CrossRefPubMed

Sampson UK, Dorbala S, Limaye A, Kwong R, Di Carli MF. Diagnostic accuracy of rubidium-82 myocardial perfusion imaging with hybrid positron emission tomography/computed tomography in the detection of coronary artery disease. J Am Coll Cardiol 2007;49:1052-8.CrossRefPubMed

Muzik O, Duvernoy C, Beanlands RS, Sawada S, Dayanikli F, Wolfe ER Jr, et al. Assessment of diagnostic performance of quantitative flow measurements in normal subjects and patients with angiographically documented coronary artery disease by means of nitrogen-13 ammonia and positron emission tomography. J Am Coll Cardiol 1998;31:534-40.CrossRefPubMed

Yoshinaga K, Katoh C, Noriyasu K, Iwado Y, Furuyama H, Ito Y, et al. Reduction of coronary flow reserve in areas with and without ischemia on stress perfusion imaging in patients with coronary artery disease: A study using oxygen 15-labeled water PET. J Nucl Cardiol 2003;10:275-83.CrossRefPubMed

Parkash R, deKemp RA, Ruddy TD, Kitsikis A, Hart R, Beauchesne L, et al. Potential utility of rubidium 82 PET quantification in patients with 3-vessel coronary artery disease. J Nucl Cardiol 2004;11:440-9.CrossRefPubMed

Kajander S, Ukkonen H, Sipilä H, Teräs M, Knuuti J. Low radiation dose imaging of myocardial perfusion and coronary angiography with a hybrid PET/CT scanner. Clin Physiol Funct Imaging 2009;29:81-8.CrossRefPubMed

Iida H, Kanno I, Takahashi A, et al. Measurement of absolute myocardial blood flow with H2 15O and dynamic positron-emission tomography. Strategy for quantification in relation to the partial-volume effect. Circulation 1988;78:104-15.PubMed

10.

Hutchins GD, Schwaiger M, Rosenspire KC, et al. Noninvasive quantification of regional blood flow in the human heart using N-13 ammonia and dynamic positron emission tomographic imaging. J Am Coll Cardiol 1990;15:1032-42.PubMedCrossRef

11.

Herrero P, Markham J, Shelton ME, Weinheimer CJ, Bergmann SR. Noninvasive quantification of regional myocardial perfusion PET and myocardial perfusion with rubidium-82 and positron emission tomography. Exploration of a mathematical model. Circulation 1990;82:1377-86.PubMed

12.

Madar I, Ravert HT, Du Y, Hilton J, Volokh L, Dannals RF, et al. Characterization of uptake of the new PET imaging compound 18F-fluorobenzyl triphenyl phosphonium in dog myocardium. J Nucl Med 2006;47:1359-66.PubMed

13.

Huisman MC, Higuchi T, Reder S, Nekolla SG, Poethko T, Wester HJ, et al. Initial characterization of an 18F-labeled myocardial perfusion tracer. J Nucl Med 2008;49:630-6.CrossRefPubMed

14.

Plössl K, Chandra R, Qu W, Lieberman BP, Kung MP, Zhou R, et al. A novel gallium bisaminothiolate complex as a myocardial perfusion imaging agent. Nucl Med Biol 2008;35:83-90.CrossRefPubMed

15.

Muzik O, Beanlands RS, Hutchins GD, et al. Validation of nitrogen-13-ammonia tracer kinetic model for quantification of myocardial blood flow using PET. J Nucl Med 1993;34:83-91.PubMed

16.

Bol A, Melin JA, Vanoverschelde JL, et al. Direct comparison of [13 N]ammonia and [15O]water estimates of perfusion with quantification of regional myocardial blood flow by microspheres. Circulation 1993;87:512-25.PubMed

17.

Lautamäki R, George RT, Kitagawa K, Higuchi T, Merrill J, Voicu C, et al. Rubidium-82 PET-CT for quantitative assessment of myocardial blood flow: Validation in a canine model of coronary artery stenosis. Eur J Nucl Med Mol Imaging 2009;36:576-86.CrossRefPubMed

18.

Hesse B, Tägil K, Cuocolo A, Anagnostopoulos C, Bardiés M, Bax J, et al. EANM/ESC procedural guidelines for myocardial perfusion imaging in nuclear cardiology. Eur J Nucl Med Mol Imaging 2005;32:855-97.CrossRefPubMed

19.

Gould KL, Pan T, Loghin C, Johnson NP, Guha A, Sdringola S. Frequent diagnostic errors in cardiac PET/CT due to misregistration of CT attenuation and emission PET images: A definitive analysis of causes, consequences, and corrections. J Nucl Med 2007;48:1112-21.CrossRefPubMed

20.

Koepfli P, Hany TF, Wyss CA, Namdar M, Burger C, Konstantinidis AV, et al. CT attenuation correction for myocardial perfusion quantification using a PET/CT hybrid scanner. J Nucl Med 2004;45:537-42.PubMed

21.

Kajander S, Ukkonen H, Joutsiniemi E, Mäki M, Saraste A, Ala-Knuuttila E, Pietilä M, Airaksinen J, Hartiala J, Saraste M, Knuuti J. The clinical value of absolute quantification of myocardial perfusion in the detection of coronary artery disease. A study using positron emission tomography to detect multi-vessel disease. Circulation 2008;118:S_1010-S_1011.

22.

Anagnostopoulos C, Almonacid A, El Fakhri G, Curillova Z, Sitek A, Roughton M, et al. Quantitative relationship between coronary vasodilator reserve assessed by 82Rb PET imaging and coronary artery stenosis severity. Eur J Nucl Med Mol Imaging 2008;35:1593-601.CrossRefPubMed

23.

Nesterov SV, Han C, Mäki M, Kajander S, Naum AG, Helenius H, Lisinen I, Ukkonen H, Pietilä M, Joutsiniemi E, Knuuti J. Myocardial perfusion quantitation with 15O-water PET: High reproducibility of the new cardiac analysis software (CarimasTM) Eur J Nucl Med Mol Imaging 2009. [Epub ahead of print].

24.

Dorbala S, Vangala D, Sampson U, Limaye A, Kwong R, Di Carli MF. Value of left ventricular ejection fraction reserve in evaluating the magnitude of myocardium at risk and the extent of angiographic coronary artery disease: A 82Rb PET/CT study. J Nucl Med 2007;48:349-58.PubMed

25.

Di Carli MF, Hachamovitch R. New technology for noninvasive evaluation of coronary artery disease. Circulation 2007;115:1464-80.CrossRefPubMed

26.

Bax JJ, Beanlands RS, Klocke FJ, Knuuti J, Lammertsma AA, Schaefers MA, et al. Diagnostic and clinical perspectives of fusion imaging in cardiology: Is the total greater than the sum of its parts? Heart 2007;93:16-22.CrossRefPubMed

27.

O’Neill JO, McCarthy PM, Brunken RC, Buda T, Hoercher K, Young JB, et al. PET abnormalities in patients with nonischemic cardiomyopathy. J Card Fail 2004;10:244-9.CrossRefPubMed

Title: Quantification of myocardial blood flow will reform the detection of CAD
Authors: Juhani Knuuti, MD
Sami Kajander, MD
Maija Mäki, MD
Heikki Ukkonen, MD
Publication date: 01-08-2009
Publisher: Springer-Verlag
Published in: Journal of Nuclear Cardiology / Issue 4/2009
Print ISSN: 1071-3581
Electronic ISSN: 1532-6551
DOI: https://doi.org/10.1007/s12350-009-9101-1

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

At a glance: The STEP trials

Springer Medicine

Quantification of myocardial blood flow will reform the detection of CAD

Excerpt

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The STEP trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 4/2009

Development and evaluation of a new fully automatic motion detection and correction technique in cardiac SPECT imaging

Attenuation corrected myocardial perfusion SPECT provides powerful risk stratification in patients with coronary artery disease

Prognostic value of myocardial perfusion scintigraphy in type 2 diabetic patients with mild, stable angina pectoris

Variations in the referral patterns to stress nuclear imaging and stress echocardiography scans

Implications of randomized studies of medical therapy vs revascularization for reducing rising costs of health care

Risk stratification with attenuation corrected stress Tc-99m sestamibi SPECT myocardial perfusion imaging in the absence of ECG-gating due to arrhythmias

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page